EFFICACY AND SAFETY STUDY OF vWF SD-35-DH (WILFACTIN) IN PATIENTS UNDER LONG TERM PROPHYLAXIS

Registry ID

EUCTR2005-001746-17

Source registry

EUCTR

Status

Completed

Phase

PHASE4

Sponsor

LFB BIOTECHNOLOGIES

Start date

2005-04-13

Completion date

2012-07-17

Last update

2026-08-16

Conditions

• von Willebrand disease

Summary

to evaluate the efficacy of vWF SD-35-DH (WILFACTIN) in a long-term prophylaxis treatment regimen for the prevention of haemorrhages.

Locations

• , , Poland
• , , Belgium

View on source registry